Dr. Thomas E. Noel, M.D.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Florida College of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 746
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: University of Florida College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
FL license ME101308
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Tallahassee Memorial Healthcare Tallahassee, FL
- Archbold Memorial Hospital Thomasville, GA
- Colquitt Regional Medical Center Moultrie, GA
Medical groups
- Tallahassee Memorial Healthcare Inc (497 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 746
- Services billed
- 1,824
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 256 | 221 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 236 | 231 |
| Established patient office or other outpatient visit, 40-54 minutes | 176 | 150 |
| Anticoagulant management of patient taking warfarin | 165 | 14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 154 | 148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 142 | 136 |
| Established patient office or other outpatient visit, 30-39 minutes | 129 | 115 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 126 | 64 |
| Blood test, clotting time | 96 | 12 |
| Ultrasound of both sides of head and neck blood flow | 60 | 60 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 49 payments worth $3,626 in total to this clinician.
| Edwards Lifesciences Corporation | $1,988 |
|---|---|
| Medtronic, Inc. | $486 |
| Abiomed | $463 |
| Abbott Laboratories | $207 |
| Shockwave Medical, Inc | $158 |
| Penumbra, Inc. | $124 |
| Stryker Corporation | $86.18 |
| Boston Scientific Corporation | $41.75 |
| Food and Beverage | $2,445 |
|---|---|
| Travel and Lodging | $1,180 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Edwards Lifesciences Corporation Jan 7, 2025 | Travel and Lodging EVOQUE · Transcatheter Valve Repair · travel to Atlanta, GA · in-kind | $647 |
| Edwards Lifesciences Corporation Jan 14, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $355 |
| Edwards Lifesciences Corporation Jan 23, 2025 | Travel and Lodging EVOQUE · Transcatheter Valve Repair · travel to Atlanta, GA · in-kind | $179 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 9 industry-funded studies in 2025, from 3 companies. The companies reported $213,454 in research payments for these studies, mostly to the institutions running them.
- EXPAND II
Medtronic, Inc. - NCT05932615--ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
Abbott Laboratories - SPYRAL AFFIRM
Medtronic, Inc. - CLASP II TR Pivotal, Study No. 2019-07
Edwards Lifesciences Corporation - TAVR Low Risk
Medtronic, Inc. - NCT03904147--TRILUMINATE Pivotal Trial
Abbott Laboratories - Low Risk Bicuspid
Medtronic, Inc. - NCT03433274--Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Abbott Laboratories - Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Abbott Laboratories · Active, not recruiting · NCT03108456
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.